Surgery in Traumatic Injury and Perioperative Considerations

Nicola Curry; Karim Brohi

doi:10.1055/s-0039-1697932

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2020; 46(01): 073-082
DOI: 10.1055/s-0039-1697932

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Surgery in Traumatic Injury and Perioperative Considerations

Authors

Nicola Curry

¹Department of Clinical Haematology, Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Trust, Churchill Hospital, Oxford, United Kingdom

²NIHR Oxford Biomedical Research Centre, Blood Theme, Oxford Centre for Haematology, Oxford University, Oxford, United Kingdom
Karim Brohi

³Centre for Trauma Sciences, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

Abstract

A severely injured patient presents several unique challenges to an admitting trauma team. Not only must the extent of the patient's injuries, particularly those that are life-threatening, be determined within minutes of hospital arrival, but also the trauma team needs to be able to assess whether the patient is bleeding and/or has an attendant coagulopathy. Early management of trauma patients is dictated by the presence (or absence) of significant bleeding. Standard definitive surgical procedures can be conducted in hemodynamically stable patients, but those in hemorrhagic shock should be treated according to damage control resuscitation (DCR) principles. DCR is a practice that has evolved over the last two to three decades, combining limited surgical techniques, which provide early hemorrhage control, and balanced transfusion resuscitation strategies, which mitigate (and ideally) treat trauma-induced coagulopathy (TIC). This review describes the contemporary perioperative management of trauma patients who have significant bleeding and/or TIC and sets out the evidence around the current approach for hemostatic resuscitation in these patients.

Keywords

damage control - hemostatic resuscitation - trauma-induced coagulopathy - perioperative management

Full Text

References

References
1 Curry N, Hopewell S, Dorée C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care 2011; 15 (02) R92
2 National Institute of Health and Clinical Excellence. Major trauma: assessment and initial management. NICE guidance [NG39]. (2016) Available at: https://www.nice.org.uk/guidance/ng39 . Accessed February 12, 2019
3 Holcomb JB, del Junco DJ, Fox EE. , et al; PROMMTT Study Group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013; 148 (02) 127-136
4 Lamb CM, MacGoey P, Navarro AP, Brooks AJ. Damage control surgery in the era of damage control resuscitation. Br J Anaesth 2014; 113 (02) 242-249
5 Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54 (06) 1127-1130
6 Zakrison TL, Leung E, McCredie V. , et al. Canadian traumatologists and the recognition of occult shock: results of a national survey. PAJT 2013; 2: 33-36
7 Wo CC, Shoemaker WC, Appel PL, Bishop MH, Kram HB, Hardin E. Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness. Crit Care Med 1993; 21 (02) 218-223
8 American College of Surgeons Committee on Trauma. Advanced Trauma Life Support for Doctors: Student Course Manual. Chicago, IL: American College of Surgeons; 2008
9 Eastridge BJ, Salinas J, McManus JG. , et al. Hypotension begins at 110 mm Hg: redefining “hypotension” with data. J Trauma 2007; 63 (02) 291-297 , discussion 297–299
10 Hasler RM, Nuesch E, Jüni P, Bouamra O, Exadaktylos AK, Lecky F. Systolic blood pressure below 110 mm Hg is associated with increased mortality in blunt major trauma patients: multicentre cohort study. Resuscitation 2011; 82 (09) 1202-1207
11 Guly HR, Bouamra O, Spiers M, Dark P, Coats T, Lecky FE. ; Trauma Audit and Research Network. Vital signs and estimated blood loss in patients with major trauma: testing the validity of the ATLS classification of hypovolaemic shock. Resuscitation 2011; 82 (05) 556-559
12 Rossaint R, Bouillon B, Cerny V. , et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 2016; 20: 100
13 Tonglet ML. Early prediction of ongoing hemorrhage in severe trauma: presentation of the existing scoring systems. Arch Trauma Res 2016; 5 (04) e33377
14 Yücel N, Lefering R, Maegele M. , et al; Polytrauma Study Group of the German Trauma Society. Trauma Associated Severe Hemorrhage (TASH)-Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma 2006; 60 (06) 1228-1236 , discussion 1236–1237
15 Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)?. J Trauma 2009; 66 (02) 346-352
16 Cantle PM, Cotton BA. Prediction of massive transfusion in trauma. Crit Care Clin 2017; 33 (01) 71-84
17 Schroll R, Swift D, Tatum D. , et al. Accuracy of shock index versus ABC score to predict need for massive transfusion in trauma patients. Injury 2018; 49 (01) 15-19
18 Cotton BA, Reddy N, Hatch QM. , et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg 2011; 254 (04) 598-605
19 Naumann DN, Khan MA, Smith JE, Rickard R, Woolley T. Future strategies for remote damage control resuscitation after traumatic hemorrhage. J Trauma Acute Care Surg 2019; 86 (01) 163-166
20 Pohlman TH, Fecher AM, Arreola-Garcia C. Optimizing transfusion strategies in damage control resuscitation: current insights. J Blood Med 2018; 9: 117-133
21 Bickell WH, Wall Jr MJ, Pepe PE. , et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994; 331 (17) 1105-1109
22 Dutton RP. Low-pressure resuscitation from hemorrhagic shock. Int Anesthesiol Clin 2002; 40 (03) 19-30
23 Cap AP, Pidcoke HF, Spinella P. , et al. Damage control resuscitation. Mil Med 2018; 183 (Suppl. 02) 36-43
24 Rotondo MF, Schwab CW, McGonigal MD. , et al. ‘Damage control’: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993; 35 (03) 375-382 , discussion 382–383
25 Wang CH, Hsieh WH, Chou HC. , et al. Liberal versus restricted fluid resuscitation strategies in trauma patients: a systematic review and meta-analysis of randomized controlled trials and observational studies. Crit Care Med 2014; 42 (04) 954-961
26 Holcomb JB, Jenkins D, Rhee P. , et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62 (02) 307-310
27 Davenport RA, Guerreiro M, Frith D. , et al. Activated protein C drives the hyperfibrinolysis of acute traumatic coagulopathy. Anesthesiology 2017; 126 (01) 115-127
28 Cohen MJ, Kutcher M, Redick B. , et al; PROMMTT Study Group. Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg 2013; 75 (01) (Suppl. 01) S40-S47
29 Frith D, Goslings JC, Gaarder C. , et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010; 8 (09) 1919-1925
30 Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion 2009; 49 (12) 2652-2660
31 Cardenas JC, Rahbar E, Pommerening MJ. , et al. Measuring thrombin generation as a tool for predicting hemostatic potential and transfusion requirements following trauma. J Trauma Acute Care Surg 2014; 77 (06) 839-845
32 Chapman MP, Moore EE, Moore HB. , et al. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg 2016; 80 (01) 16-23 , discussion 23–25
33 Esmon CT. The protein C pathway. Chest 2003; 124 (3, Suppl): 26S-32S
34 Brohi K, Cohen MJ, Ganter MT. , et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64 (05) 1211-1217 , discussion 1217
35 Raza I, Davenport R, Rourke C. , et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11 (02) 307-314
36 Simmons JW, Powell MF. Acute traumatic coagulopathy: pathophysiology and resuscitation. Br J Anaesth 2016; 117 (Suppl. 03) iii31-iii43
37 Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011; 254 (02) 194-200
38 Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg 2012; 73 (01) 60-66
39 Solomon C, Traintinger S, Ziegler B. , et al. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost 2011; 106 (02) 322-330
40 Kutcher ME, Redick BJ, McCreery RC. , et al. Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg 2012; 73 (01) 13-19
41 Vulliamy P, Gillespie S, Gall LS, Green L, Brohi K, Davenport RA. Platelet transfusions reduce fibrinolysis but do not restore platelet function during trauma hemorrhage. J Trauma Acute Care Surg 2017; 83 (03) 388-397
42 Martini WZ, Chinkes DL, Pusateri AE. , et al. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endocrinol Metab 2005; 289 (05) E930-E934
43 Wolberg AS, Campbell RA. Thrombin generation, fibrin clot formation and hemostasis. Transfus Apheresis Sci 2008; 38 (01) 15-23
44 Booth C, Allard S. Major haemorrhage protocols. ISBT Sci Ser 2018; 13: 219-228
45 Dzik WH. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004; 3 (05) 324-330
46 Young PP, Cotton BA, Goodnough LT. Massive transfusion protocols for patients with substantial hemorrhage. Transfus Med Rev 2011; 25 (04) 293-303
47 Shakur H, Roberts I, Bautista R. , et al; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376 (9734): 23-32
48 Holcomb JB, Tilley BC, Baraniuk S. , et al; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313 (05) 471-482
49 Moore HB, Moore EE, Chapman MP. , et al. Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet 2018; 392 (10144): 283-291
50 Sperry JL, Guyette FX, Brown JB. , et al; PAMPer Study Group. Prehospital plasma during air medical transport in trauma patients at risk for haemorrhagic shock. N Engl J Med 2018; 379 (04) 315-326
51 Schafer N, Driessen A, Frohlich M. , et al. ; TACTIC partners. Diversity in clinical management and protocols for the management of major bleeding of trauma patients across European level 1 Trauma Centres. Scand J Trauma Resusc Emerg Med 2015; 23: 74
52 Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I. ; Antifibrinolytic Trials Collaboration. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet 2018; 391 (10116): 125-132
53 Roberts I, Shakur H, Afolabi A. , et al; CRASH-2 collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377 (9771): 1096-1101 , 1101.e1–1101.e2
54 Lord JM, Midwinter MJ, Chen YF. , et al. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet 2014; 384 (9952): 1455-1465
55 Zehtabchi S, Nishijima DK. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 2009; 16 (05) 371-378
56 Murad MH, Stubbs JR, Gandhi MJ. , et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 2010; 50 (06) 1370-1383
57 Kozar RA, Peng Z, Zhang R. , et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 2011; 112 (06) 1289-1295
58 Watson JJ, Pati S, Schreiber MA. Plasma transfusion: history, current realities, and novel improvements. Shock 2016; 46 (05) 468-479
59 Khan S, Davenport R, Raza I. , et al. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med 2015; 41 (02) 239-247
60 Perkins JG, Cap AP, Spinella PC. , et al. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009; 66 (4, Suppl): S77-S84 , discussion S84–S85
61 Inaba K, Lustenberger T, Rhee P. , et al. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg 2010; 211 (05) 573-579
62 Shaz BH, Dente CJ, Nicholas J. , et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010; 50 (02) 493-500
63 Hallet J, Lauzier F, Mailloux O. , et al. The use of higher platelet: RBC transfusion ratio in the acute phase of trauma resuscitation: a systematic review. Crit Care Med 2013; 41 (12) 2800-2811
64 Cotton BA, Gunter OL, Isbell J. , et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008; 64 (05) 1177-1182 , discussion 1182–1183
65 del Junco DJ, Holcomb JB, Fox EE. , et al; PROMMTT Study Group. Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg 2013; 75 (01) (Suppl. 01) S24-S30
66 Davenport RA, Brohi K. Cause of trauma-induced coagulopathy. Curr Opin Anaesthesiol 2016; 29 (02) 212-219
67 Curry NS, Davenport R, Pavord S. , et al. The use of viscoelastic haemostatic assays in the management of major bleeding: a British Society for Haematology Guideline. Br J Haematol 2018; 182 (06) 789-806
68 Whiting P, Al M, Westwood M. , et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess 2015; 19 (58) 1-228
69 Gonzalez E, Moore EE, Moore HB. , et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg 2016; 263 (06) 1051-1059
70 Innerhofer P, Fries D, Mittermayr M. , et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol 2017; 4 (06) e258-e271
71 Bakaas-Aasen K, Van Dieren S, Balvers K. , et al , the TACTIC/INTRN collaborators. Data-driven development of ROTEM and TEG algorithms for the management of trauma hemorrhage. A prospective observational multicenter study. Annals of Surg 2018; (e-pub ahead of print)
72 Wong H, Curry N. Do we need cryoprecipitate in the era of fibrinogen concentrate and other specific factor replacement options?. ISBT Sci Ser 2018; 13: 23-28
73 Rourke C, Curry N, Khan S. , et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10 (07) 1342-1351
74 Schöchl H, Cotton B, Inaba K. , et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15 (06) R265
75 Curry N, Rourke C, Davenport R. , et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth 2015; 115 (01) 76-83
76 Curry N, Foley C, Wong H. , et al. Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial. Crit Care 2018; b 22 (01) 164
77 Nascimento B, Callum J, Tien H. , et al. Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth 2016; 117 (06) 775-782
78 Marsden M, Benger J, Brohi K. , et al on behalf of the CRYOSTAT-2 investigators. Coagulopathy, cryoprecipitate and CRYOSTAT-2 realising the potential of a nationwide trauma system for a national clinical trial. Br J Anaesth 2019; 122 (02) 164-169
79 Adams SD, Holcomb JB. Geriatric trauma. Curr Opin Crit Care 2015; 21 (06) 520-526
80 Ruff CT, Giugliano RP, Braunwald E. , et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383 (9921): 955-962
81 Gómez-Outes A, Terleira-Fernández A-I, Calvo-Rojas G, Suárez-Gea ML, Vargas-Castrillón E. Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta-analysis by geographic region with a focus on European patients. Br J Clin Pharmacol 2016; 82 (03) 633-644
82 Lecky FE, Omar M, Bouamra O. , et al. The effect of preinjury warfarin use on mortality rates in trauma patients: a European multicentre study. Emerg Med J 2015; 32 (12) 916-920
83 Oake N, Fergusson DA, Forster AJ, van Walraven C. Frequency of adverse events in patients with poor anticoagulation: a meta-analysis. CMAJ 2007; 176 (11) 1589-1594
84 Keeling D, Baglin T, Tait C. , et al. British Committee for Standards in Haematology. Guidelines on oral anticoagulation with warfarin – fourth edition. Br J Haematol 2011; 154: 311-324
85 Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, Pendry K. ; British Committee for Standards in Haematology. A practical guideline for the haematological management of major haemorrhage. Br J Haematol 2015; 170 (06) 788-803
86 Hunt BJ, Neal MD, Stensballe J. Reversing anti-factor Xa agents and the unmet needs in trauma patients. Blood 2018; 132 (23) 2441-2445
87 Bliden KP, Chaudhary R, Mohammed N. , et al. Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system. J Thromb Thrombolysis 2017; 43 (04) 437-445
88 Connolly SJ, Crowther M, Eikelboom JW. , et al; ANNEXA-4 Investigators. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med 2019; 380 (14) 1326-1335
89 Gilstad C, Roschewski M, Wells J. , et al. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood. Transfusion 2012; 52 (05) 930-935
90 Seheult JN, Bahr M, Anto V. , et al. Safety profile of uncrossmatched, cold-stored, low-titer, group O+ whole blood in civilian trauma patients. Transfusion 2018; 58 (10) 2280-2288
91 Brohi K, Gruen RL, Holcomb JB. Why are bleeding trauma patients still dying?. Intensive Care Med 2019; 45 (05) 709-711
92 Mira JC, Brakenridge SC, Moldawer LL, Moore FA. Persistent inflammation, immunosuppression and catabolism syndrome. Crit Care Clin 2017; 33 (02) 245-258